STOCK TITAN

Medical Properties Trust (NYSE: MPW) SVP sells 2,000 shares of stock at $5

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medical Properties Trust Inc. reported that its SVP of Operations sold 2,000 shares of common stock on 12/15/2025 at a price of $5 per share.

After this sale, the officer directly owned 395,182 shares of Medical Properties Trust common stock. No derivative securities transactions were reported in the derivative securities table.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hooper Rosa Handley

(Last) (First) (Middle)
1000 URBAN CENTER DRIVE
SUITE 501

(Street)
BIRMINGHAM AL 35242

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP of Operations
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 12/15/2025 S 2,000 D $5 395,182 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
W. Zachary Riddle, by power of attorney 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Medical Properties Trust (MPW) disclose?

The SVP of Operations of Medical Properties Trust Inc. sold 2,000 shares of common stock on 12/15/2025 at a price of $5 per share.

Who is the reporting person and what is their role at Medical Properties Trust (MPW)?

The reporting person is an officer of Medical Properties Trust Inc., serving as SVP of Operations.

How many Medical Properties Trust shares does the officer own after the sale?

Following the reported transaction, the officer directly owned 395,182 shares of Medical Properties Trust common stock.

What type of security was involved in the MPW insider transaction?

The transaction involved common stock of Medical Properties Trust Inc., with a par value of $0.001 per share.

Were any derivative securities reported for the Medical Properties Trust insider?

No derivative securities transactions were reported; the derivative securities table did not list any acquired or disposed instruments.

Was this Medical Properties Trust insider transaction reported by one or multiple persons?

The report was filed as a Form filed by one reporting person, not by a group.

Medical Prop

NYSE:MPW

MPW Rankings

MPW Latest News

MPW Latest SEC Filings

MPW Stock Data

3.04B
497.66M
17.3%
59.5%
27.66%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
BIRMINGHAM